☆ 4.3 Letter

Dupilumab, an emerging therapeutic choice for recalcitrant subepidermal autoimmune bullous diseases: a case series of three patients

EUROPEAN JOURNAL OF DERMATOLOGY (2021)

Get Full Text
Add to Collection

Journal

EUROPEAN JOURNAL OF DERMATOLOGY
Volume 31, Issue 6, Pages 846-847

Publisher

JOHN LIBBEY EUROTEXT LTD
DOI: 10.1684/ejd.2021.4190

Keywords

-

Categories

Dermatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.